Jianguo Cheng, MD, PhD, Director of the Multidisciplinary Pain Management Fellowship at Cleveland Clinic, and colleagues are on a mission to improve pain education for physicians and the public. They are working in conjunction with the American Academy of Pain Medicine.
Addressing the challenge of opioid tolerance and overdose, Cleveland Clinic research finds new treatment option may improve opioid therapy.
Studies at Cleveland Clinic have demonstrated the effectiveness of mesenchymal stem cell (MSC) transplantation in reducing hyperalgesia caused by nerve injury. Jianguo Cheng, MD, PhD, talks about findings from animal studies.
Medications aimed at reducing headache can actually make them worse. It is far better to prevent rebound headache with strict limits on medication use, but the syndrome is treatable.